Patient Acceptance, Ease of Use, and Preference for Norditropin NordiFlex with NordiFlex PenMate: Results from an Open-Label, User Survey of Everyday Use

In this 12-week open-label, uncontrolled study, patients (n = 85; mean [SD] age 11.2 [3.95] years) were trained to use an injection device with an automatic needle insertion accessory (NordiFlex/NordiFlex PenMate: Novo Nordisk A/S, Bagsvaerd, Denmark) for growth hormone (GH) injection. The opinions...

Descripción completa

Detalles Bibliográficos
Autores principales: Hokken-Koelega, Anita, Keller, Alexandra, Rakov, Viatcheslav, Kipper, Stefan, Dahlgren, Jovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262649/
https://www.ncbi.nlm.nih.gov/pubmed/22363887
http://dx.doi.org/10.5402/2011/803948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262649/
https://www.ncbi.nlm.nih.gov/pubmed/22363887
http://dx.doi.org/10.5402/2011/803948

Ejemplares similares